Management tracks

Antibody and cell therapy company Sorrento Therapeutics Inc. (NASDAQ:SNRE) hired Jerome Zeldis as CMO and president of clinical development. Zeldis was CMO of Celgene Corp. (NASDAQ:CELG) and CEO of its Celgene Global Health unit.

Rare disease company Retrophin Inc. (NASDAQ:RTRX) named Neil McFarlane COO. He was VP and general manager at the UCB Inc. subsidiary of UCB Group (Euronext:UCB). ...